Ernexa’s Promising Cancer Trial Advances with FDA Success
Ernexa Therapeutics has completed a Pre-IND meeting with FDA and is targeting an IND submission to support a first-in-human...
Oxford, MDxHealth Validate GPS Test in Prostate Cancer Trial
More than 1,500 men with localized prostate cancer and over two decades of outcomes data from the UK ProtecT...
Sparrow Enrolls First Patient in Phase 2b Diabetes Trial
Sparrow Pharmaceuticals has enrolled the first patient in CAPTAIN-T2D, a double-blind Phase 2b study of clofutriben, an oral 11β-HSD1...
Taysha Reports Progress in Rett Syndrome Gene Therapy Study
Single-arm pivotal trial initiated in Q4 2025 is dosing 15 females with Rett syndrome (ages 6 to <22) with...
MindRank’s Promising AI Oral GLP-1 Enters Phase III Trial
MindRank’s Phase IIb data for MDR-001 showed a 10.3% mean weight reduction at Week 24 in 317 participants, with...
Alumis Reports Phase 3 Envudeucitinib Psoriasis Data
No efficacy or safety data yet. Alumis will release topline results from the Phase 3 ONWARD program of envudeucitinib,...
Medera’s Successful Heart Trial Enrollment Now Complete
No gene therapy–related serious adverse events have been reported to date across both cohorts in Medera’s Phase 1/2a MUSIC-HFpEF...
Soleno Announces Successful Pivotal Study Results for Vykat
In a 16-week randomized withdrawal study of 77 individuals with Prader-Willi syndrome (PWS), discontinuation to placebo led to a...
New Drug Combo Enters Phase III Trial for Pancreatic Cancer
In the Phase II portion of HUTCHMED’s randomized Phase II/III study in first-line metastatic pancreatic ductal adenocarcinoma (PDAC), the...
Study Finds Babesia Infection in 24% of Chronic Fatigue Cases
Babesia DNA was detected in 24% of a 50‑patient cohort with at least six months of fatigue and concurrent...